Cooper Companies | COO - Stock


Cooper Companies reported $896.4M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Abbott USD 6.99B 501M Mar/2026
Align Technology USD 212.24M 2.7M Jun/2026
AtriCure USD 83.92M 2.78M Jun/2026
Bausch Health Companies USD 1.6B 1000K Jun/2026
Baxter International USD 2.26B 57M Jun/2026
Bayer EUR 11.97B 43M Jun/2026
Becton, Dickinson and Co. USD 3.32B 41M Jun/2026
Boston Scientific USD 3.24B 118M Jun/2026
Cooper Companies USD 896.4M 20M Mar/2026
Dentsply International USD 665M 6M Jun/2026
Dexcom USD 726.4M 32.8M Jun/2026
Edwards Lifesciences USD 1.13B 12.2M Jun/2026
Globus Medical USD 810.9M 38.3M Jun/2026
Haemonetics USD 306.74M 369K Jun/2026
Inogen USD 25.08M 762K Sep/2025
Insulet USD 484.8M 22.3M Jun/2026
Integra LifeSciences USD 492M 3.03M Jun/2026
Intuitive Surgical USD 2.03B 83.6M Jun/2026
J&J USD 15.14B 561M Jun/2026
Medtronic USD 6.22B 264M Jun/2026
Merit Medical Systems USD 374.11M 21.73M Jun/2026
Novartis USD 6.29B 135M Mar/2026
ResMed USD 945.8M 33.93M Jun/2026
STAAR Surgical USD 46.84M 2.95M Jun/2026
Steris USD 712.1M 80.3M Jun/2026
Stryker USD 5.52B 102M Jun/2026
Tandem Diabetes Care USD 135.11M 8.71M Jun/2026
Teleflex USD 351.91M 28.95M Jun/2026
Utah Medical Products 8.12M 115K Sep/2025
Zimmer Biomet Holdings USD 2.27B 23.5M Jun/2026